Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

NCT03401060 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT03401060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 3
Overall status
Completed
Start date
March 5, 2018
Completion date
March 11, 2024
Enrollment
24 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, systemic mastocytosis